Investor Update

Reminder: Invitation to Roche’s Half Year Results 2021 Presentation

Roche will publish its Half Year Results of 2021 prior to the opening of the Swiss Stock Exchange on Thursday, 22nd July 2021.

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here
Presentation slides will be posted on the Roche IR website > click here

We would like to invite all interested parties to watch the live video webcast.
14:00 - 15:30 CEST / 13:00 - 14:30 BST
08:00 - 09:30 AM EDT / 05:00 - 06:30 AM PDT

The webinar will start with presentations by senior management, followed by a Q&A session.


  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer
We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*
Should you be unable to register for the webinar due to your company IT policy, please send an email to

A replay of the webcast will be available via >
*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations

Roche Investor Relations 
Dr. Karl Mahler
Phone: +41 61 68-78503
Jon Kaspar Bayard
Phone: +41 61 68-83894
Dr. Sabine Borngräber
Phone: +41 61 68-88027
Dr. Bruno Eschli
Phone: +41 61 68-75284
Dr. Birgit Masjost
Phone: +41 61 68-84814
Dr. Gerard Tobin
Phone: +41 61 68-72942
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217